| For: | Gao Z, Wang XY, Shen ZG, Liu JH, Wang XY, Wu SK, Jin X. Real-world comparison of chemotherapy plus bevacizumab with or without immunotherapy as first-line therapy in colorectal cancer. World J Gastroenterol 2025; 31(24): 108298 [PMID: 40599189 DOI: 10.3748/wjg.v31.i24.108298] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i24/108298.htm |
| Number | Citing Articles |
| 1 |
Chang Zhang, Shi-Hao Wu, Lei Jin, Liang Lu, Ji Li, Shui Jin. Propensity score-based real-world study of immune checkpoint inhibitor combination therapy in microsatellite stable/proficient mismatch repair metastatic colorectal cancer. World Journal of Gastrointestinal Oncology 2026; 18(11): 124022 doi: 10.4251/wjgo.124022
Abstract(6) |
Core Tip(9) |
Full Article(HTML)(0)
|
Full Article (PDF)-2815K(0)
|
Full Article with Cover (PDF)-3129K(0)
|
Full Article (XML)-193K(4)
|
Audio-2087K(0)
|
Peer-Review Report-277K(6)
|
Answering Reviewers-293K(6)
|
Supplementary Material-357K(4)
|
Times Cited (0)
|
Total Visits (640)
|
Open
|
| 2 |
Jiamin Lu, Yuqian Feng, Kaibo Guo, Hong Pan. Prognostic value of the systemic immune-inflammation index in gastrointestinal cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-05014-x
|